Question-1- (a) The above-mentioned ECG strip represents atrial fibrillation. It is a common form of observed cardiac arrhythmia, which is represented by a loss of “P-wave” in the ECG strip. It is marked by an irregular and rapid heartbeat or heart rate (Freedman, 2016). This condition can increase the chances of development of stroke in an individual and can also cause further heart-related complications. The cardiac arrhythmia in atrial fibrillation is found to be caused by irregularity in the flow of atriums or upper chambers of the heart. These chambers do not attain pumping action in sync with the lower chambers or ventricles of the heart and thus, creating an emergent situation for the patient. Missed or rapid conduction in the upper chambers of the heart, brings about an added pressure on the heart vessels and thus, repetition of this phenomenon can cause life-threatening condition for the patient as well (Staerk, 2017). If atrial fibrillation goes untreated, it can lead to clot formation in the upper chambers of heart, which is well-connected with some of the major arteries in the body. This can cause blood flow obstruction and ischemia in various organs of the body.
(b) There are multiple reasons for development of atrial fibrillation. Three of the main attributing reasons can be as enlisted below:
(c) The treatment options of atrial fibrillation can be in multiple forms. Some of the commonly used methods are as mentioned-below:
Question-2 (a) The arterial blood gas analysis of the patient indicates respiratory acidosis. Respiratory acidosis is marked by respiratory insufficiency in the patient. This insufficiency brings about a hampered potential of the patient to evacuate out carbon dioxide from the lings. The increase in the value of partial level of carbon dioxide in blood and low pH indicates an acidic nature of blood developing in the body. The pH of the blood is supposed to be maintained at a neutral value so that proper gaseous exchange can be executed by the lungs and thus, maintaining a normal inspiration and expiration ratio. Acidosis in blood in indicated in blood with a pH value below 7.35. Respiratory acidosis can lead to the patient developing a ventilatory failure (González, 2018). Due to increased value of carbon dioxide, they can get mixed in the lungs through ventilation process and not get adequately flushed out of the system, leading to carbon dioxide toxicity. Pulmonary edema in the lungs is marked by fluid filled in air passages of lungs due to gaseous exchange abnormality. This condition can be both acute and chronic. The condition of pulmonary edema can be directly associated with respiratory acidosis as there is a major imbalance in the gaseous exchange. With respiratory failure occurring in respiratory acidosis, the patient can develop acute pulmonary edema as well (Belenguer, 2017).
(b) Acute pulmonary edema in the lungs can be marked by a rapid fluid buildup in the lungs. This fluid is generally filled in lower passages such as alveoli and interstitium. This further hampers with the pulmonary circulation in the lungs (Bhattacharya, 2016). With the slow progressive building up of fluid the air passages further constrict and thus, decreasing the lungs’ capacity for adequate gaseous exchange and reduced lung compliance as well. This can also accumulate in the patient causing symptoms such as hypoxia and dyspnoea. Acute pulmonary edema can be cardiogenic in nature or non-cardiogenic. Cardiogenic acute pulmonary edema can be reflected in the patient in terms of reduced cardiac output, whereas, non-cardiogenic acute pulmonary edema can be reflected as the patient having reduced vascular permeability.
(c) The treatment of patient having acute pulmonary edema can be as follow:
Nursing interventions- The nurses can cater to the medical needs of this patient in the following ways:
Question-3 (a) A secondary survey of the patient is generally conducted when all potential life-threatening conditions are avoided. A composite assessment of the patient is carried out in this method. The various aspects that are covered in this condition include the following:
(b) The three common respiratory signs that can be observed in the patient in the given case scenario include:
The patient in the given case study should be monitored on an hourly basis for vitals such as heart rate, respiratory rate, blood pressure, blood oxygen saturation etc. The lab test of arterial blood gas analysis should also be done, to keep a close vigil on the gaseous abnormality (Fanari, 2019). This will be helpful in altering the dose of medication and oxygen supplement to be provided to the patient. Blood pressure readings are to be monitored specifically to this case, as the readings will be helpful in altering the dosage of diuretics in the patient, used for managing acute pulmonary edema.
Agrawal, N., Kumar, A., Aggarwal, P., & Jamshed, N. (2016). Sympathetic crashing acute pulmonary edema. Indian Journal of Critical Care Medicine: Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine, 20(12), 719. https://dx.doi.org/10.4103%2F0972-5229.195710
Assaad, S., Kratzert, W. B., Shelley, B., Friedman, M. B., & Perrino Jr, A. (2018). Assessment of pulmonary edema: Principles and practice. Journal of Cardiothoracic and Vascular Anesthesia, 32(2), 901-914. https://doi.org/10.1053/j.jvca.2017.08.028
Belenguer-Muncharaz, A., Mateu-Campos, L., González-Luís, R., Vidal-Tegedor, B., Ferrándiz-Sellés, A., Árguedas-Cervera, J., ... & Moreno-Clarí, E. (2017). Non-invasive mechanical ventilation versus continuous positive airway pressure relating to cardiogenic pulmonary edema in an intensive care unit. Archivos De Bronconeumología, 53(10), 561-567. https://doi.org/10.1016/j.arbres.2017.02.005
Benke, C., Hamm, A. O., & Pané‐Farré, C. A. (2017). When dyspnea gets worse: Suffocation fear and the dynamics of defensive respiratory responses to increasing interoceptive threat. Psychophysiology, 54(9), 1266-1283. https://doi.org/10.1111/psyp.12881
Bhattacharya, M., Kallet, R. H., Ware, L. B., & Matthay, M. A. (2016). Negative-pressure pulmonary edema. Chest, 150(4), 927-933. https://doi.org/10.1016/j.chest.2016.03.043
Cardona-Morrell, M., Prgomet, M., Lake, R., Nicholson, M., Harrison, R., Long, J., ... & Hillman, K. (2016). Vital signs monitoring and nurse–patient interaction: A qualitative observational study of hospital practice. International Journal of Nursing Studies, 56, 9-16. https://doi.org/10.1016/j.ijnurstu.2015.12.007
Chao, T. F., Lip, G. Y., Liu, C. J., Lin, Y. J., Chang, S. L., Lo, L. W., ... & Chen, T. J. (2018). Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation. Journal of the American College of Cardiology, 71(2), 122-132. https://doi.org/10.1016/j.jacc.2017.10.085.
Choi, E. K., Han, K. D., Lee, E. J., Lee, S. R., Cha, M. J., & Oh, S. (2019). Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: a nationwide population-based study in Korea. Diabetes Research and Clinical Practice, 148, 14-22. https://doi.org/10.1016/j.diabres.2018.12.004
Fanari, Z., Mohammed, A. A., Bathina, J. D., Hodges, D. T., Doorey, K., Gagliano, N., ... & Doorey, A. J. (2019). Inadequacy of pulse oximetry in the catheterization laboratory. An exploratory study monitoring respiratory status using arterial blood gases during cardiac catheterization with conscious sedation. Cardiovascular Revascularization Medicine, 20(6), 461-467. https://doi.org/10.1016/j.carrev.2018.07.027.
Freedman, B., Potpara, T. S., & Lip, G. Y. (2016). Stroke prevention in atrial fibrillation. The Lancet, 388(10046), 806-817. https://doi.org/10.1016/S0140-6736(16)31257-0
Gil, V., Domínguez-Rodríguez, A., Masip, J., Peacock, W. F., & Miró, Ò. (2019). Morphine use in the treatment of acute cardiogenic pulmonary edema and its effects on patient outcome: A systematic review. Current Heart Failure Reports, 16(4), 81-88. https://doi.org/10.1007/s11897-019-00427-0
González, S. B., Menga, G., Raimondi, G. A., Tighiouart, H., Adrogué, H. J., & Madias, N. E. (2018). Secondary response to chronic respiratory acidosis in humans: a prospective study. Kidney International Reports, 3(5), 1163-1170. https://doi.org/10.1016/j.ekir.2018.06.001
Kumar, M., & Thompson, P. D. (2019). A literature review of immersion pulmonary edema. The Physician and Sports Medicine, 47(2), 148-151. https://doi.org/10.1080/00913847.2018.1546104
Lee, K., & Kim, S. H. (2020). Patients' and nurses' perceptions of what constitutes good nursing care: An integrative review. Research and Theory for Nursing Practice, 34(2), 144-169. https://doi.org/10.1891/RTNP-D-19-00070
Lopes, R. D., Rordorf, R., De Ferrari, G. M., Leonardi, S., Thomas, L., Wojdyla, D. M., ... & Hanna, M. (2018). Digoxin and mortality in patients with atrial fibrillation. Journal of the American College of Cardiology, 71(10), 1063-1074. https://doi.org/10.1016/j.jacc.2017.12.060
Moinzadeh, A. T., De Moor, R. J., & De Bruyne, M. A. (2018). Influence of a calcium hydroxide-based intracanal dressing on the quality of the root canal filling assessed by capillary flow porometry. Clinical Oral Investigations, 22(4), 1733-1739. https://doi.org/10.1007/s00784-017-2267-z
Pascual, I., Moris, C., & Avanzas, P. (2016). Beta-blockers and calcium channel blockers: first line agents. Cardiovascular Drugs and Therapy, 30(4), 357-365. https://doi.org/10.1007/s10557-016-6682-1
Plitt, A., Ezekowitz, M. D., De Caterina, R., Nordio, F., Peterson, N., Giugliano, R. P., & ENGAGE AF‐TIMI 48 Investigators. (2016). Cardioversion of atrial fibrillation in ENGAGE AF‐TIMI 48. Clinical Cardiology, 39(6), 345. https://dx.doi.org/10.1002%2Fclc.22537
Ramkumar, S., Yang, H., Wang, Y., Nolan, M., Negishi, K., Sanders, P., & Marwick, T. H. (2017). Relation of functional status to risk of development of atrial fibrillation. The American Journal of Cardiology, 119(4), 572-578. https://doi.org/10.1016/j.amjcard.2016.10.043
Romero, J., Kumar, S., Akira, F., Briceño, D. F., Tedrow, U. B., Epstein, L., ... & Michaud, G. F. (2017). Emergence of atrioventricular nodal reentry tachycardia after surgical or catheter ablation for atrial fibrillation: Are we creating the arrhythmia substrate?. Heart Rhythm, 14(11), 1637-1646. https://doi.org/10.1016/j.hrthm.2017.08.002
Staerk, L., Sherer, J. A., Ko, D., Benjamin, E. J., & Helm, R. H. (2017). Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circulation Research, 120(9), 1501-1517. https://doi.org/10.1161/CIRCRESAHA.117.309732
Remember, at the center of any academic work, lies clarity and evidence. Should you need further assistance, do look up to our Nursing Assignment Help
Proofreading and Editing$9.00Per Page
Consultation with Expert$35.00Per Hour
Live Session 1-on-1$40.00Per 30 min.
Doing your Assignment with our resources is simple, take Expert assistance to ensure HD Grades. Here you Go....